Jeffrey Miller is president and CEO of NewArc Investments, a registered investment adviser, and Capital Markets Research. He also serves on the board of directors for Helix BioMedix and Think-A-Move. Miller has been director of research for KTZ Trading, and taught political science and public affairs for the University of Wisconsin and Lawrence University. Miller is the author of numerous articles and papers on taxation, policymaking and the equities market. He holds a bachelor’s degree from Bowling Green State University and master’s and doctorate degrees from the University of Michigan.
Miller writes about the market, interpreting data, and finding the right expert at his blog, “A Dash of Insight. He is writing about the 2008 presidential campaign and the implications for individual stocks and the market at Election Stocks. His investment company, with programs for both individual and institutional investors, is NewArc Investments.
To chat with Jeff Miller about his Investment strategies, please sign up for a WallStreetAllStars.com platinum subscription and click here.
Jeff’s latest columns:
With stocks hitting new highs and the bull market reaching age five, the potential for a market top is a popular subject. There is a light schedule of economic releases, so pundits will be free to spend nearly full time explaining the rally and offering their forecasts. Expect even more articles like [...]
SOXX is iShares PHLX Semiconductor ETF. It rated number two and is out of the penalty box (NewArc Investments does hold this ETF). IBB is the top rated ETF which we discussed last week. But. this week it is out of the penalty box and our company, NewArc Investments, does hold it as well for our Felix trading […]
Employment remains the paramount concern – for the economy, for the Fed, and for financial markets. There are many employment indicators, but that can be more confusing than helpful. Rarely is there a consistent picture. Can we find more clarity about employment? Last Week’s Theme Recap I expected last [...]
IBB is iShares Nasdaq Biotechnology ETF. It is ranked number two as GDX is still hogging the top spot. The model’s results are as of yesterday. As of today, IBB is a holding in our Felix model. Investor Take IBB reflects the inverse of a P/E ratio of 41.86 and a yield of .03%. That is one of the […]
Housing data have clearly hit a soft patch. How much of the deceleration is important? How much can be attributed to weather? Most importantly: Does weakness in housing threaten the economic recovery? What does it mean for stocks? [note to readers. I always try for weekend publication, but sometimes I cannot [...]
Wall Street All-Stars RSS» Jeff Miller